Dual translocation of MYC and BCL2 in patients with DLBCL is termed “double-hit lymphoma” (DHL), and dual protein overexpression of MYC and BCL2 without underlying translocations is termed “double-expressor lymphoma” (DEL). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.